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Background. A number of scales are used to estimate the severity of depression. However, diﬀerences between self-
report and clinician rating, multi-dimensionality and diﬀerent weighting of individual symptoms in summed scores
may aﬀect the validity of measurement. In this study we examined and integrated the psychometric properties of three
commonly used rating scales.
Method. The 17-item Hamilton Depression Rating Scale (HAMD-17), the Montgomery–Asberg Depression Rating
Scale (MADRS) and the Beck Depression Inventory (BDI) were administered to 660 adult patients with unipolar
depression in a multi-centre pharmacogenetic study. Item response theory (IRT) and factor analysis were used to
evaluate their psychometric properties and estimate true depression severity, as well as to group items and derive factor
scores.
Results. The MADRS and the BDI provide internally consistent but mutually distinct estimates of depression severity.
The HAMD-17 is not internally consistent and contains several items less suitable for out-patients. Factor analyses
indicated a dominant depression factor. A model comprising three dimensions, namely ‘observed mood and anxiety’,
‘cognitive’ and ‘neurovegetative’, provided a more detailed description of depression severity.
Conclusions. The MADRS and the BDI can be recommended as complementary measures of depression severity. The
three factor scores are proposed for external validation.
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Introduction
A valid and reliable measure of the severity of de-
pression is required to judge the need for care, assess
treatment eﬀects, and inform aetiological explorations.
Although a number of scales are available, the agree-
ment between them is less than optimal and no
instrument can be considered as a gold standard.
In this article, we identify the factors aﬀecting the
measurement of depression severity and address
these in the comparison and integration of three in-
struments : the clinician-rated 17-item Hamilton
Depression Rating Scale (HAMD-17; Hamilton, 1960,
1967), the Montgomery–Asberg Depression Rating
Scale (MADRS; Montgomery & Asberg, 1979) and the
self-report 21-item Beck Depression Inventory (BDI ;
Beck et al. 1961).
The ﬁrst issue concerns the distinction between
self-report and clinician-rated scales. Traditionally,
clinician-rated instruments were assumed to be more
objective and valid than self-report (Prusoﬀ et al. 1972).
However, it has been suggested that the larger eﬀect
size of clinician-rated scales compared to self-report
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in clinical trials might be due to a clinician’s bias in
favour of active medication rather than to true sensi-
tivity to change (Edwards et al. 1984 ; Greenberg et al.
1992). Other studies have found that self-report in-
ventories have a validity and sensitivity to change
comparable to the clinician-rated HAMD (Feinberg
et al. 1981 ; Rush et al. 2005). It is our view that, as
the depressive syndrome comprises subjective symp-
toms and observable signs, it is natural to combine
clinician observation with self-report when measuring
its severity. While some symptoms require clinical
observation (e.g. psychomotor retardation), others
hinge on self-report even in clinician-led assessment
(e.g. guilt), and yet other symptoms may be more
easily rated by self-report because of their intimate
nature (e.g. libido). Somewhat surprisingly, the two
methods of assessment have often been contrasted but
rarely integrated (Gullion & Rush, 1998). In the pres-
ent investigation, we combined two clinician-rated
scales and one self-report questionnaire to derive an
estimate of depression severity.
The second issue is the dimensional complexity of
depression. Although depressed mood and anhedonia
form the core of the depressive syndrome, other signs
and symptoms contribute to the distress and impair-
ment associated with the disorder, and should be
taken into account when assessing its severity. Con-
sequently, the intensity and frequency of symptoms
have to be weighted, as well as their level of related-
ness to the concept of depression. The existing scales
diﬀer in their emphasis on various groups of symp-
toms and in the range of symptoms included. For
example, the HAMD-17 includes one item for mood
but three items assessing sleep. The MADRS includes
two mood items but only one sleep item. Pessimism
and guilt are assessed by six of the 21 items of the
BDI compared to one item of the MADRS or the
HAMD-17. Anxiety is rated in four HAMD-17 items,
one item of the MADRS and one of the BDI. As the
scales are scored by summing their items, each
instrument is biased towards symptoms covered by
more items (Moller, 2001 ; Bagby et al. 2004). A method
of rectifying this bias by selecting only items
assessing the core depressive symptomatology has
been proposed (Bech et al. 1975, 2000). In the present
study, we explored an alternative solution of applying
the item response theory (IRT; Embretson & Reise,
2000), which is a method of looking at how informa-
tive each item is in a particular sample. IRT methods
are based on probabilities of individual response op-
tions and estimate depression severity independently
of the selection of test items.
If depression is a multi-dimensional construct,
it would be best assessed by several related scales
measuring the underlying dimensions (Gibbons et al.
1993). Indeed, there is evidence for several dimensions
of depressive symptoms that diﬀer in their aetiology
(Korszun et al. 2004). A number of studies have
addressed the dimensionality of depression scales by
means of factor analysis, and found that most scales
are better described as comprising 3–6 dimensions
(Shafer, 2006). While the factor analytic studies
have reliably indicated a subset of core items that
can be scored as an internally consistent scale (Bech
et al. 1975 ; Faries et al. 2000 ; Shafer, 2006), they have
failed to provide useful subscales for other aspects
of depressive symptomatology (Gibbons et al. 1993;
Browne et al. 1995). The failure to ﬁnd practical multi-
dimensional descriptors has two possible expla-
nations. First, with a notable exception (Gullion &
Rush, 1998), previous studies have analysed items
belonging to a single scale, and there have been in-
suﬃcient additional items to cover dimensions other
than the one reﬂecting core depressive symptoma-
tology. Second, in aiming for the most accurate
description of the covariance structure, authors have
tended to extract a large number of factors that were
insuﬃciently deﬁned by a relatively small number
of items. In the present investigation, we aimed to
achieve a pragmatic balance between model ﬁt and
applicability.
Method
Sample and design
The interviews (HAMD-17 and MADRS) and ques-
tionnaire (BDI) were administered to 236 male and 424
female adult patients with major depressive disorder
as part of their participation in GENDEP (genome-
based therapeutic drugs for depression), a multi-
centre randomized pharmacogenetic study (http://
gendep.iop.kcl.ac.uk). The participants were between
18 and 72 years old (mean 41.8, S.D.=11.8) and of white
European ethnicity. They were predominantly out-
patients, recruited through referrals and advertise-
ments in eight European countries including Belgium
(n=37), Croatia (n=39), Denmark (n=72), Germany
(n=194), Italy (n=35), Poland (n=97), Slovenia
(n=108) and the UK (n=78). The inclusion criterion
was a diagnosis of major depressive episode of at least
moderate severity, as deﬁned by the DSM-IV and
ICD-10 and established in the Schedules for Clinical
Assessment in Neuropsychiatry (SCAN Version 2.1 ;
WHO, 1999) with the computerized classiﬁcation sys-
tem CATEGO5 (Grayson et al. 1990). The exclusion
criteria were : a ﬁrst-degree relative with bipolar af-
fective disorder or schizophrenia, a history of hypo-
manic or manic episode, mood incongruent psychotic
symptoms, primary substance misuse or primary or-
ganic disease, current treatment with an antipsychotic
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or a mood stabilizer, pregnancy or lactation. Par-
ticipants were also excluded if they had medical
contra-indications or a history of lack of eﬃcacy or
adverse reactions to both study medications. After
explanation of study procedures and providing in-
formed consent as approved by local ethical commit-
tees, the participants were randomized to receive
escitalopram or nortriptyline for 12 weeks. Eighty-nine
participants had a history of non-response, adverse
eﬀects or contra-indications to one study medication
and were non-randomly allocated to the other medi-
cation. All assessment scales were administered at
week 0 (at randomization) and then weekly for 12
weeks. Assessments at weeks 0, 8 and 12 were face-
to-face interviews with a psychiatrist and a research
assistant, both trained in the administration of the in-
struments. The remaining assessments were conduc-
ted either face-to-face or by telephone interview with a
trained psychologist or psychiatrist. To establish inter-
rater reliability for HAMD-17 and MADRS, 10 inter-
views were audio-recorded and rated by raters in each
centre.
Measures
The HAMD-17 was used in its 1967 revision
(Hamilton, 1967) with standardized prompts and an-
chors that have been shown to improve the reliability
of ratings (Williams, 1988). The 17 items and their
range of response options are : (1) depressed mood
0–4; (2) feelings of guilt 0–4 ; (3) suicide 0–4 ; (4) early
insomnia 0–2 ; (5) middle insomnia 0–2; (6) late in-
somnia 0–2 ; (7) work and activities 0–4 ; (8) retardation
0–4 ; (9) agitation 0–4 ; (10) psychic anxiety 0–4 ; (11)
somatic anxiety 0–4 ; (12) gastrointestinal somatic
symptoms/appetite 0–2 ; (13) general somatic symp-
toms 0–2; (14) genital symptoms 0–2; (15) hypochon-
driasis 0–4; (16) loss of weight 0–2 ; and (17) insight
0–2. They were rated to cover the 1-week period prior
to the interview. In addition to the full-scale version,
we evaluated the six-item version (HAMD-6), com-
prising items 1, 2, 7, 8, 10 and 13, which has better
internal consistency (Bech et al. 1975).
The MADRS was administered in its original form
(Montgomery & Asberg, 1979). It comprises 10 items
with six ordered response categories (0–5) each:
(1) apparent sadness ; (2) reported sadness ; (3) inner
tension; (4) reduced sleep; (5) reduced appetite ;
(6) concentration diﬃculties ; (7) lassitude ; (8) inability
to feel ; (9) pessimistic thoughts ; and (10) suicidal
thoughts.
The original 21-item version of the BDI (Beck et al.
1961) was completed as a paper-and-pencil self-report
questionnaire, or it was read out to the participants,
giving them all response options and asking them to
select the one that best corresponded to how they had
been feeling over the preceding week. The BDI com-
prises 21 items, each scored 0–3: (1) sadness, (2) future
pessimism; (3) feeling like a failure ; (4) lack of enjoy-
ment ; (5) guilt ; (6) feelings of being punished; (7) dis-
appointment with oneself ; (8) self-blame; (9) suicidal
thoughts ; (10) crying; (11) irritability ; (12) interest
in people ; (13) making decisions ; (14) appearance ;
(15) work; (16) sleep; (17) tiredness ; (18) appetite ;
(19) weight loss ; (20) health anxiety ; and (21) interest
in sex.
Approach to analysis
Some investigators have used one measure as a ‘gold
standard’ criterion for assessing the validity of other
scales. However, several ‘gold standards’, including
the HAMD, have proven unreliable (Bagby et al. 2004;
Ruhe et al. 2005). Therefore, recognizing that no
measure on its own is optimal, we used an IRT model
to derive the best estimate of true depression severity
from the composite pool of items of the three rating
scales.
Repeated assessments of the same individual tend
to be related, and inclusion of multiple assessments
could bias the psychometric parameter estimates.
Therefore, most investigators include only one time
point per individual when psychometric properties of
a scale are investigated. As variability in symptom
ratings at study entry tends to be limited, most
previous psychometric studies have focused on exit
ratings. Exit ratings contain more variability but may
be biased by having severe ratings only in treatment-
resistant subjects, and may be inﬂuenced by the
psychological factors related to ending a study. It is
our opinion that if the purpose is to measure the eﬀect
of treatment, it is important to examine the psycho-
metric properties across the treatment period.
Therefore, we randomly selected 1 week from each
individual to derive a ‘random week dataset ’ for the
item response calibration and factor analyses. If all
ratings for the randomly selected week were missing,
adjacent week data were used for that individual.
Dimensionality and factor structure
The factor analysis in the present report serves several
related purposes. First, conﬁrmatory factor analysis
(CFA) was applied to test the assumption of uni-
dimensionality, which is a prerequisite for scoring
under classical test theory (CTT) and IRT. Uni-
dimensionality is characterized by a single dominant
factor that explains a large proportion of the variance
(Embretson & Reise, 2000). After testing the di-
mensionality of each scale separately, we applied a
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one-factor CFA to the items of the three scales to test
the presumption that they measured the same concept
(depression severity). Although a degree of uni-
dimensionality is necessary for summed scale scores
to be valid, it was not expected that a one-factor model
would provide the best ﬁt to a scale with more than a
few items (Floyd & Widaman, 1995). Following the
procedure used by the Patient-Reported Outcomes
Measurement Information System (PROMIS) Consor-
tium (www.nihpromis.org), we evaluated practical
indices including the factor loadings, average absolute
residual correlation, root mean square error of
approximation (RMSEA), the incremental ﬁt index
of Tucker and Lewis (TLI) and the comparative ﬁt
index (CFI).
Second, if one-factor CFA did not provide a close ﬁt
to the data, an exploratory factor analysis (EFA) was
performed to obtain a ﬁne-grained description of the
scale covariance structure. As appropriate for the or-
dered categorical response format of HAMD, MADRS
and BDI, conﬁrmatory and exploratory analyses were
performed on a matrix of polychoric correlations
using the robust weighted least square estimator
(Flora & Curran, 2004) in Mplus version 4.2 (Muthen
& Muthen, 2006). As dimensions of depression are
expected to be related, we used oblique PROMAX
rotation, allowing factors to be correlated.
The number of factors to be extracted in the EFA
was determined by comparison of data-derived
eigenvalues, with the distribution of eigenvalues in a
parallel analysis of 25 simulated datasets with the
same proportion of response categories and missing
values as in the observed data. The same factor
analytic procedure and estimator were used for the
simulated as for the real data. Parallel analysis has
been shown to be superior to the commonly used
eigenvalue-greater-than-one rule and other methods
of determining the number of factors (Humphreys &
Montanelli, 1975).
Finally, we performed a longitudinal CFA to test
how the structure derived from the random week
dataset generalized to speciﬁc time points and to test
longitudinal measurement invariance (Brown, 2006).
Classical test theory (CTT)
Depression severity is not directly observable and has
to be derived from a set of questionnaire or interview
items. The CTT provides a theoretical framework for
such inference. We used the CTT correlation-based
methods to assess the scale internal consistency (a
measure of correlation between items reﬂected in
item-total correlation and Cronbach’s a), construct
validity (factor analysis) and criterion validity (cor-
relation between measures). CTT methods assume
that all items measure the same construct (uni-
dimensionality) with equal accuracy (parallelism) and
independently of each other and of the true score
(random errors) across individuals and occasions
(measurement invariance). While some of these
assumptions may be unrealistic, we included here the
CTT methods for the sake of comparability with
previous literature, while the IRT analysis provides
a more generalizable model.
Item response theory (IRT)
IRT methods estimate a latent trait (depression sever-
ity) based on the pattern of responses to all available
items. The probability of each response option
is modelled across the severity spectrum. The IRT de-
rives estimates independent of the selection of ad-
ministered items and allows the error of measurement
to vary along the spectrum of severity (Embretson &
Reise, 2000). The IRT only retains the assumptions of
unidimensionality (i.e. all test items relate to one
underlying concept) and local independence (i.e. the
errors are uncorrelated for a speciﬁed level of sever-
ity). Using marginal maximum likelihood and the
MULTILOG 7 software (Thissen et al. 2003), we ﬁtted
the IRT graded response model for ordered poly-
tomous items (Samejima, 1969). For each test item, we
calculated its ability to discriminate between levels of
severity (discrimination parameter a) and a series of
response option thresholds (b1–6). A discrimination
parameter a below 0.65 is considered low, 0.65x1.34
moderate and 1.35 or above high (Baker, 2001).
Threshold parameters reﬂect the standardized level of
depression severity at which subsequent response
options become more probable than the previous
option. For example, a ﬁrst threshold parameter b1 of
x1.5 indicates that an individual with severity of
less than 1.5 standard deviation (S.D.) below average
is most likely to score 0 on this item. A second
threshold b2 of 0.0 indicates that an individual with
average severity will be equally likely to score 1 or 2.
An optimal test has items with high discrimination
and response thresholds spread across a range of
severity.
We further calculated the test information function
(TIF), which is deﬁned as the inverse of measure-
ment error and gives a detailed account of scale
accuracy across the spectrum of severity. Finally, we
used the technique of summed scores (Orlando et al.
2000) and the IRTscore software (Flora & Thissen,
2002) to estimate the test scores equivalent to each
level of depression severity. The resulting equivalent
score table facilitated the comparison of HAMD,
MADRS and BDI scores across settings and indi-
viduals.
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Results
Missing values
In the random week dataset, 2.6% of the values were
missing and average inter-item covariance coverage
was 96%. Most of the missing data were due to one of
the three scales being omitted: 24 participants did not
provide data on BDI (e.g. had not posted it back), two
participants did not have HAMD-17 and two did not
have MADRS rating. Furthermore, 52 participants did
not answer the last three BDI items, which were on
the last page. Twelve participants (1.8%) had missing
values on HAMD item 14 (genital symptoms), com-
pared to an average of 2–3 missing values (<0.5%)
for other items. Both Mplus and MULTILOG allow
the use of all available data and provide unbiased
estimates in the presence of missing values.
Reliability and summed scores of rating scales
Internal consistency was high for MADRS and BDI
(Cronbach’s ao0.9) and acceptable for the HAMD-17
and HAMD-6 (Cronbach’s ao0.8 ; Table 1). The
corrected item-total correlations were low (<0.4)
for the HAMD items 9 (agitation), 14 (libido), 15
(hypochondriasis), 16 (weight loss) and 17 (insight)
and the BDI item 19 (weight loss). All MADRS items
had adequate item-total correlations (>0.5).
The summed scores for the random week data ran-
ged from levels indicating severe depression to com-
plete recovery and their means corresponded to
moderate depression (Table 1). The correlations of
summed scores ranged from 0.75 between BDI and
HAMD to 0.92 betweenMADRS and HAMD (Table 1).
Inter-rater reliability assessed by intra-class corre-
lation was 0.90 [95% conﬁdence interval (CI) 0.79–
0.96] for the HAMD-17 and 0.92 (95% CI 0.83–0.97) for
the MADRS, and did not diﬀer signiﬁcantly between
centres.
One-factor CFA
First, we tested the unidimensionality of each scale
using a CFA with all items loading on a single com-
mon factor. A one-factor CFA of the 10 MADRS items
showed a good ﬁt, with a single common factor ex-
plaining 57% of the variance, all factor loadings above
0.6 (data not shown), and low mean residual corre-
lation (Table 2). These results indicated that MADRS
was eﬀectively a unidimensional measure. For the
Table 1. Descriptive statistics, internal consistency and mutual correlation of summed scores of the diﬀerent scales
n Min Max Mean S.D. Cronbach’s a
Correlations
MADRS HAMD-17 BDI
MADRS 652 0 49 18.59 10.24 0.91
HAMD-17 653 0 37 13.61 7.59 0.85 0.92
HAMD-6 653 0 19 7.24 4.00 0.80 0.88 0.92 0.72
BDI 627 0 55 18.70 11.55 0.92 0.77 0.75
MADRS, Montgomery–Asberg Depression Rating Scale ; HAMD-17, 17-item Hamilton Depression Rating Scale ; HAMD-6,
six-item Hamilton Depression Rating Scale ; BDI, Beck Depression Inventory.
Table 2. Conﬁrmatory factor analysis (CFA) as unidimensionality test of the original measures
Number
of items
Number of
individuals
Proportion of
variance explained
Average absolute
residual correlation TLI CFI RMSEA
MADRS 10 653 0.57 0.03 0.99 0.97 0.10
HAMD-17 17 654 0.36 0.06 0.93 0.87 0.09
HAMD-6 6 654 0.48 0.04 0.99 0.98 0.07
BDI 21 626 0.48 0.06 0.97 0.88 0.10
All items 48 656 0.45 0.09 0.90 0.63 0.17
TLI, Incremental ﬁt index of Tucker and Lewis ; CFI, comparative ﬁt index ; RMSEA, root mean square error of
approximation ; MADRS, Montgomery–Asberg Depression Rating Scale ; HAMD-17, 17-item Hamilton Depression Rating
Scale ; HAMD-6, six-item Hamilton Depression Rating Scale ; BDI, Beck Depression Inventory.
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HAMD-17, a one-factor CFA model explained 36%
of the variance and four item loadings were less
than 0.6 (items: 9 agitation, 14 genital symptoms, 15
hypochondriasis, 17 insight) ; low residual correlations
indicated that the items with a poor ﬁt were not
strongly mutually related (Table 2). The HAMD-6
appeared unidimensional, with a model ﬁt similar to
the MADRS. For the BDI, a single-factor model ex-
plained 48% of variance and model ﬁt was inter-
mediate, suggesting that although an adequate level of
unidimensionality was present, there was room for
factorial exploration.
Second, to test the presumption that all three scales
measured one underlying construct, a CFA was per-
formed forcing all 48 items to load on one common
factor. This common factor explained 45% of the
variance and 43 items had loadings of 0.60 or more;
HAMD items 9, 11, 15 and 17 and BDI items 19 and 20
had smaller loadings. Although the strong common
factor supported unidimensionality, the model ﬁt in-
dices suggested that the one-factor model does not
provide an exhaustive description (Table 2).
Exploratory factor analysis (EFA)
As the one-factor CFA did not provide a close ﬁt, we
performed an EFA. The HAMD item 17 (insight) had a
limited distribution (92% of ratings=0) and weak
correlations with other items (all less than 0.2), and
tended to produce a singleton factor ; we therefore
excluded it and applied the EFA to the remaining
47 items. The high ratio (6.1) of ﬁrst to second
eigenvalues was consistent with unidimensionality.
However, the ﬁrst six eigenvalues exceeded the dis-
tribution of values derived from a parallel analysis of
random data, indicating a more complex factorial
structure (Fig. 1). The diﬀerence between observed
and simulated data eigenvalues decreased progress-
ively and was relatively smaller for the fourth, ﬁfth
and sixth factor. We have therefore examined solu-
tions with up to six factors.
The three-factor solution provided the most parsi-
monious and interpretable description with few cross-
loadings. The PROMAX rotated solution is presented
in Table 3. The ﬁrst ‘observed mood and anxiety’
factor comprised clinician-rated anxiety, mood, and
activity items. The second ‘cognitive’ factor was satu-
rated by suicide, guilt, and most self-rated BDI items
including pessimism and self-deprecation. The third
‘neurovegetative’ factor included appetite, weight
loss, sleep and sexual drive.
In the four-factor solution, the neurovegetative
factor separated into sleep-sex and appetite-weight
factors. In the ﬁve-factor solution, the cognitive factor
separated into guilt and interest factors. Finally, if six
factors were extracted, the anxiety items separated
from the remaining items in factor 1, but clinician-
rated mood items cross-loaded onto the anxiety
factor.
Longitudinal three-factor conﬁrmatory analysis
A longitudinal factor analysis conﬁrmed that the EFA-
derived three-factor structure was largely invariant
over time. Factors 1 and 3 were invariant across all
time points including baseline. Constraining factor 2
loadings at week 0 (baseline) to the same values
as follow-up weeks led to a small deterioration but
the model ﬁt remained acceptable (RMSEA<0.05).
Detailed results of the longitudinal CFA are available
on request from R.U.
Item response analysis
A graded response model was ﬁtted to all 48 items,
excluding response categories for which there were no
observations (category 6 of MADRS items 3, 7 and 9
and category 4 of HAMD items 8 and 15). The dis-
crimination and threshold parameters for each item
are given in Table 4. Although most items showed
appropriate discrimination properties, HAMD items 9
and 17 contributed little to the measurement of de-
pression severity. Overall, the MADRS items provided
best discrimination (average a=1.9), BDI items were
intermediate (average a=1.4) and HAMD items low-
est (average a=1.2). The thresholds covered a broad
spectrum of severity from x2 to +3 of the standard-
ized h scale. Mood and activity items discriminated at
milder severity levels, whereas suicide, appetite and
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Fig. 1. Exploratory factor analysis (EFA) eigenvalues (–$–)
compared with parallel analysis (. . .1. . .). Parallel analysis
shows the information contained in factors based on random
data. The number of true factors present is estimated as the
number of real data eigenvalues in the EFA that exceed the
parallel analysis values.
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Table 3. Exploratory factor analysis (EFA) : three-factor solution with PROMAX rotated loadings
1 2 3
Item Observed mood Cognitive Neurovegetative
Mood observed MADRS 1 0.72 0.27 0.03
Mood reported MADRS 2 0.68 0.30 0.04
Tension MADRS 3 0.93 x0.12 x0.08
Sleep MADRS 4 0.35 x0.26 0.77
Appetite MADRS 5 x0.10 0.04 0.97
Concentration MADRS 6 0.47 0.26 0.11
Lassitude MADRS 7 0.62 0.24 0.06
Inability to feel MADRS 8 0.52 0.35 0.04
Pessimism MADRS 9 0.36 0.64 x0.16
Suicide MADRS 10 x0.16 0.86 0.23
Mood HAMD 1 0.60 0.30 0.09
Guilt HAMD 2 0.28 0.72 x0.20
Suicide HAMD 3 x0.19 0.90 0.24
Sleep, early HAMD 4 0.23 x0.07 0.52
Sleep, middle HAMD 5 0.27 x0.18 0.61
Sleep, late HAMD 6 0.28 x0.20 0.71
Activity HAMD 7 0.56 0.20 0.08
Retardation HAMD 8 0.37 0.26 0.05
Agitation HAMD 9 0.50 x0.06 x0.11
Anxiety, psychic HAMD 10 0.92 x0.15 x0.08
Anxiety, somatic HAMD 11 0.77 x0.19 0.03
Appetite HAMD 12 x0.05 0.03 0.93
Somatic symptoms HAMD 13 0.50 0.12 0.13
Sexual HAMD 14 x0.18 0.35 0.50
Hypochondriasis HAMD 15 0.44 x0.03 0.12
Weight loss HAMD 16 x0.02 0.09 0.62
Sadness BDI 1 0.29 0.49 0.14
Future BDI 2 0.16 0.62 0.06
Failure BDI 3 0.00 0.84 x0.11
Enjoyment BDI 4 0.23 0.54 0.14
Guilt BDI 5 0.06 0.81 x0.16
Punished BDI 6 0.04 0.67 x0.13
Disappointed BDI 7 x0.07 0.89 x0.09
Blame self BDI 8 x0.01 0.85 x0.15
Suicide BDI 9 x0.14 0.81 0.15
Crying BDI 10 0.11 0.46 0.21
Irritable BDI 11 0.16 0.41 0.18
Interest in people BDI 12 0.17 0.55 0.13
Decisions BDI 13 0.21 0.52 0.12
Ugly BDI 14 0.04 0.60 x0.03
Work BDI 15 0.38 0.39 0.12
Sleep BDI 16 0.25 x0.02 0.64
Tired BDI 17 0.24 0.36 0.21
Appetite BDI 18 x0.09 0.15 0.80
Weight loss BDI 19 x0.07 0.10 0.56
Health worry BDI 20 0.33 0.17 0.11
Sexual interest BDI 21 x0.20 0.37 0.54
Bold values represent highest loading for each item.
MADRS, Montgomery–Asberg Depression Rating Scale ; HAMD, Hamilton Depression Rating Scale ; BDI, Beck Depression
Inventory.
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Table 4. Item response characteristics. The discrimination parameter a is a measure of the item’s ability to discriminate varied levels of
depression severity. The threshold parameters b show the standardized level of severity at which subsequent response options become more
likely than the previous response option. Categories with no observations are omitted
Item
Discrimination Response option thresholds
a b1 b2 b3 b4 b5 b6
Mood observed MADRS 1 2.54 x1.30 x0.57 0.22 0.98 1.96 2.95
Mood reported MADRS 2 2.69 x1.48 x0.70 0.02 0.79 1.70 2.78
Tension MADRS 3 1.35 x1.72 x1.09 0.49 1.86 3.83
Sleep MADRS 4 1.31 x1.01 x0.52 0.25 1.02 2.39 4.04
Appetite MADRS 5 1.37 0.35 0.61 1.39 2.42 3.82 4.36
Concentration MADRS 6 1.72 x1.45 x0.77 0.33 1.31 3.18 4.14
Lassitude MADRS 7 2.04 x1.65 x0.73 0.34 1.08 2.62
Inability to feel MADRS 8 2.18 x1.24 x0.51 0.49 1.25 2.31 3.61
Pessimism MADRS 9 1.88 x1.17 x0.49 0.82 1.79 3.21
Suicide MADRS 10 1.94 0.03 0.99 1.84 2.33 3.24 3.84
Mood HAMD 1 2.53 x1.33 x0.14 0.88 2.08
Guilt HAMD 2 1.59 x0.69 0.63 2.79 4.80
Suicide HAMD 3 2.11 0.45 1.50 2.37 4.01
Sleep, early HAMD 4 0.92 0.30 1.62
Sleep, middle HAMD 5 0.93 x0.12 1.70
Sleep, late HAMD 6 1.07 0.25 1.31
Activity HAMD 7 1.69 x1.55 x0.22 0.92 2.15
Retardation HAMD 8 1.18 0.40 2.14 4.69
Agitation HAMD 9 0.51 0.90 3.54 6.30 10.09
Anxiety, psychic HAMD 10 1.18 x1.56 0.16 1.80 4.09
Anxiety, somatic HAMD 11 0.91 x0.78 0.91 3.04 7.56
Appetite HAMD 12 1.40 0.57 2.86
Somatic symptoms HAMD 13 1.27 x0.85 1.25
Sexual HAMD 14 0.88 x1.16 0.71
Hypochondriasis HAMD 15 0.74 0.70 3.08 5.57
Weight loss HAMD 16 1.11 2.19 3.04
Insight HAMD 17 0.43 6.58 13.68
Sadness BDI 1 2.13 x0.90 0.88 2.18
Future BDI 2 1.74 x0.92 0.77 2.06
Failure BDI 3 1.39 x0.50 1.03 2.70
Enjoyment BDI 4 2.02 x1.13 0.72 1.96
Guilt BDI 5 1.29 x0.44 1.15 2.75
Punished BDI 6 1.00 0.46 1.65 2.15
Disappointed BDI 7 1.38 x0.78 1.88 2.90
Blame self BDI 8 1.28 x0.67 1.40 2.63
Suicide BDI 9 1.75 0.63 2.27 3.34
Crying BDI 10 1.38 x0.02 1.44 1.77
Irritable BDI 11 1.32 x0.86 1.18 2.29
Interest in people BDI 12 1.76 x0.58 0.99 2.40
Decisions BDI 13 1.56 x1.18 0.26 2.27
Ugly BDI 14 1.01 0.14 1.58 3.19
Work BDI 15 1.75 x1.22 0.66 2.39
Sleep BDI 16 1.36 x0.72 0.75 1.95
Tired BDI 17 1.44 x1.31 0.82 2.57
Appetite BDI 18 1.32 0.41 1.78 2.93
Weight loss BDI 19 0.88 2.39 3.98 5.05
Health worry BDI 20 0.92 0.16 1.94 4.62
Sexual interest BDI 21 0.94 x1.03 0.40 1.42
MADRS, Montgomery–Asberg Depression Rating Scale ; HAMD, Hamilton Depression Rating Scale ; BDI, Beck Depression
Inventory.
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retardation discriminated at the severe end of the
spectrum. The very high b6 thresholds for most
MADRS and b4 thresholds for HAMD items reﬂected
the fact that the highest options were rarely used in the
clinician-rated scales.
The IRT-derived true score of depression severity
(h) correlated 0.95, 0.92, 0.90 and 0.90 with the
MADRS, HAMD-17, HAMD-6 and BDI total scores
respectively. The accuracy of measurement across the
spectrum of depression severity was reﬂected in the
total test information curves (Fig. 2). These showed an
advantage for the MADRS and BDI over HAMD
across the severity spectrum. The MADRS adequately
covered a broad range of severity from x1.6 to 3.0 of
the standardized h scale. Table 5 provides the most
likely summed scores for each instrument corre-
sponding to diﬀerent levels of the IRT true score of
depression severity.
Discussion
By including the three most commonly used instru-
ments for measuring the severity of depression in
a large sample, the GENDEP study has provided
an opportunity for a comprehensive psychometric
comparison of the three scales. The CTT and IRT re-
sults were in agreement, indicating that of the three
instruments examined here, MADRS provided the
most accurate reﬂection of depression severity in a
predominantly out-patient sample. It was internally
consistent and measured depression accurately over
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Fig. 2. Total test information : total test information is the
inverse of measurement error and reﬂects the accuracy of
depression severity estimation. It varies with the level of
depression severity shown in standardized units. –$–,
Montgomery–Asberg Depression Rating Scale ; – –1– –,
Beck Depression Inventory ; . . .&. . ., 17-item Hamilton
Depression Rating Scale.
Table 5. Equivalent summed scores estimates. h is the IRT estimate
of depression severity in a standardized z score
h BDI MADRS HAMD-17 HAMD-6
x2.4 0 0 0 0
x2.3 1 0 0 0
x2.2 1 0 0 0
x2.1 1 1 1 0
x2 2 1 1 0
x1.9 2 2 1 0
x1.8 3 2 2 1
x1.7 3 3 2 1
x1.6 4 3 3 1
x1.5 4 4 3 1
x1.4 5 5 4 2
x1.3 6 6 4 2
x1.2 6 6 5 2
x1.1 7 7 5 3
x1 8 8 6 3
x0.9 9 9 7 3
x0.8 10 10 7 4
x0.7 11 11 8 4
x0.6 12 12 9 5
x0.5 13 13 9 5
x0.4 14 14 10 5
x0.3 15 15 11 6
x0.2 16 16 11 6
x0.1 17 17 12 7
0 18 18–19 13 7
0.1 19 20 14 8
0.2 20 21 15 8
0.3 21–22 22 16 9
0.4 23 23 17 9
0.5 24 24 17 10
0.6 25 25 18 10
0.7 26 26 19 11
0.8 27–28 27–28 20 11
0.9 29 29 21 11
1 30 30 22 12
1.1 31–32 31 23 12
1.2 33 32 24 13
1.3 34 33 25 13
1.4 35–36 34 26 14
1.5 37 35 27 14
1.6 38–39 36 27 15
1.7 40 37 28 15
1.8 41 38 29 15
1.9 42 39 30 16
2 43–44 40 31 16
2.1 45 41 32 16
2.2 46 42 33 17
2.3 47–48 43 33 17
2.4 49 44 34 18
2.5 50 45 35 18
2.6 51 46 36 18
2.7 52 47 37 19
2.8 53 48 37 19
IRT, Item response theory ; BDI, Beck Depression
Inventory ; MADRS, Montgomery–Asberg Depression
Rating Scale ; HAMD-17, 17-item Hamilton
Depression Rating Scale ; HAMD-6, six-item Hamilton
Depression Rating Scale.
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a broad range of severity. The most severe MADRS
response category (6) was rarely applied, suggesting
that there was a margin for measuring depression in
severe cases not routinely included in out-patient
trials. Our results replicated a previous study demon-
strating an advantage of MADRS over HAMD in out-
patient clinical trial samples (Carmody et al. 2006). For
practical purposes MADRS can be considered to be
unidimensional, although four of its items loaded on
factors other than the core depression severity, and
separation of these factors may help in a detailed
examination of depressive symptomatology.
The self-report BDI was internally consistent and
provided accurate measurement across a broad spec-
trum of depression severity. However, the BDI ap-
peared to measure a distinct ‘cognitive’ dimension of
depression, which was strongly correlated but not
identical with the observer-rated depression. Even
items measuring mood and activity were more
highly correlated with other self-report items than
with clinician-rated items of corresponding content.
As the study has not been able to distinguish the
relative validity of clinician rating and self-report, we
propose that the two approaches should be regarded
as distinct and complementary, and their relative
and joint merits should be explored in their various
applications.
In the present sample, the HAMD-17 proved to be
internally less consistent and to have provided a less
accurate measurement of depression. Several items
had limited distribution of values and had little re-
lationship to other items. These were insight, agitation,
hypochondriasis and genital symptoms, which have
been found to have poor psychometric properties in
numerous previous investigations (Rehm & O’Hara,
1985 ; Santor & Coyne, 2001; Bagby et al. 2004 ; Evans
et al. 2004 ; Carmody et al. 2006). The apparent poor
results may have been due to a mismatch between the
population under study and the sample on which the
HAMD was developed and validated. The HAMD-17
was developed for use with psychiatric in-patients
diagnosed with unipolar and bipolar aﬀective dis-
order but went on to become the most common scale
used in treatment trials on unipolar depressed out-
patients (Elkin et al. 1989 ; Bagby et al. 2004). Although
lack of insight is common among hospitalized
patients, it would be ethically unacceptable to recruit
insightless individuals (who would lack capacity to
give informed consent) into a randomized treatment
trial. It was therefore not surprising that, on 92%
occasions, lack of insight was rated as 0 in the
present study. Another item with poor distribution
of values was agitation; observable agitation is
meaningful among severely depressed in-patients
whereas it is less consistent with daily functioning and
participation in an out-patient trial. In the present
sample, agitation was strongly associated with anxi-
ety, and added little information beyond that obtained
from the anxiety items.
In view of the large diﬀerences in psychometric
properties between items, it is legitimate to seek short
versions without problematic items. We therefore in-
vestigated the properties of the HAMD-6 (Bech et al.
1975), which appeared to be unidimensional. Its items
were more discriminatory and related more to the core
concept of depression than other HAMD-17 items.
However, it provided less information on depression
severity (while not plotted separately in Fig. 2, the
total test information of any item subset cannot sur-
pass that of the full scale as it is a sum of information of
individual items) and, compared to MADRS, showed
marginally lower correlation, with the best estimate of
true depression severity derived from all three scales.
Therefore, the MADRS showed better psychometric
properties compared to any reduced version of the
HAMD.
A single score of depression severity is attractive for
practical purposes and the IRT score provided its best
available estimate. However, the syndrome of de-
pression is complex and, especially in the context of
aetiological research, may best be described by several
related dimensions. We propose an interpretable
three-factor solution as a descriptive system for future
research. The observed mood and anxiety, cognitive
and neurovegetative factors closely replicated those
derived from symptom ratings in a diagnostic inter-
view, which were shown to diﬀer in their aetiology
(Korszun et al. 2004). It was also consistent with
dimensions derived from factorial analyses of indi-
vidual scales (Shafer, 2006) and mapped well to the
rather complex 10-factor solution derived in a study
integrating self-report and clinician-rated instruments
(Gullion & Rush, 1998). Extraction of up to six factors
is supported by the parallel analysis, and in the six-
factor solution, each of the three main factors sep-
arated into two facets. However, item cross-loading,
ﬂoor eﬀects in factor scores and small number of
items in some of the six factors indicated that the
three-factor solution was more viable. The usefulness
of the three factors as opposed to individual scales
and the total IRT score needs to be tested by external
validation.
Several methodological issues bear on the compar-
ability of the present study with previous investi-
gations. First, on the assumption that depression has
a subjective and objective component, we have in-
tegrated the items of self-rated and clinician-rated in-
struments in a single analysis. This led to a degree of
redundancy : for example, there was an item for mood,
activity or suicide on each scale. Such redundancy did
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not inﬂuence the IRT score estimation; in contrast to
summed scores, addition of another item with the
same threshold and same response did not change the
score estimate under the IRT framework. However,
the inclusion of a number of similar items may have
inﬂuenced the results of the EFA by deﬁning a strong
factor. Thus it is likely that, for example, the failure of
the hypochondriasis and health anxiety items to
strongly load onto any factor was simply because too
few related items were included. We contend that the
item composition of the three commonly used scales
is a good reﬂection of the concept of depression.
Moreover, an apparent content overlap does not
necessarily mean redundancy. For example, the ﬁnd-
ing that mood items of self-report and clinician-rated
scales load on distinct factors was enlightening.
Second, we have extracted one rating per individual
randomly. The results of the longitudinal CFA in-
dicated that the factor structure derived from the ran-
dom sample generalized to diﬀerent time points
and was largely invariant over time. However, a rep-
lication in an independent sample is needed to estab-
lish the generalizability of the ﬁndings.
In conclusion, we have compared three commonly
used instruments for measuring depression severity in
a large sample of depressed out-patients. We conclude
that the MADRS and BDI provide internally valid but
slightly discordant estimates of depression severity.
The HAMD-17 does not appear to be suitable for out-
patient samples. We propose an overall score derived
from the combined pool of clinician-rated and self-
rated items as well as three speciﬁc factor scales for
external validation in future research.
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